4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-017691
CHIEF OPERATING OFFICER sold 17,300 shares at $28.28 ($489,244)
- CHIEF OPERATING OFFICER acquired 6,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-16 | Option exercise 10b5-1 | +6,500 | $8.83 | $57,395 | 78,863 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-16 | Sale 10b5-1 | −17,300 | $28.28 | $489,244 | 61,563 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-16 | Option exercise · Share Option 10b5-1 | −6,500 | 38,500 | D | ||
| Open-market sales · 17,300 sh · avg $28.28 · $489,244 | |||||||
Loading xslF345X05/form4-06182025_080651.xml…